骨桥蛋白和白介素-18在糖尿病肾病患者血清中的表达及其意义
|
摘要
目的
本研究通过检测糖尿病肾病患者不同时期血清骨桥蛋白和白细胞介素-18水平变化,旨在探讨二者在糖尿病肾病发生发展中的作用及二者之间是否存在相关性,从而为2型糖尿病肾病的发病机制及演变过程的认识提供新的思路。
方法
选取2009年12月-2010年12月在泰安市中心医院确诊的2型糖尿病患者90例,糖尿病诊断符合2008年美国糖尿病学会(American diabetes association,ADA)的诊断标准。根据尿白蛋白排泄率(UAER)分为3组:单纯2型DM组(DM1组)30例(UAER<20μg/min)。微量白蛋白尿组(DM2组)30例:(UAER 20μg-200μg/min)。临床蛋白尿组(DM3组)30例: (UAER > 200μg/min)。正常对照组(NC组)30例,为体检正常者。性别、年龄两组无统计学差异。采用酶联免疫吸附试验(Enzyme-linked immunosorbent assay,ELISA)测定血清骨桥蛋白(OPN)及白介素-18(IL-18)水平,24小时尿白蛋白排泄率(UAER)采用放免法测定。
结果
1、与健康对照组相比,糖尿病肾病各组在年龄、腰臀比、体重指数方面差异无统计学意义(P>0.05),具有可比性;与健康对照组比较,糖尿病各组收缩压、舒张压、空腹血糖、餐后2h血糖、糖化血红蛋白显著升高,差异有统计学意义(P<0.01)。
2、糖尿病肾病各组血清OPN浓度显著高于正常对照组(P<0.01),血清OPN与UAER成正相关(P<0.01),与空腹血糖(FBG)、餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1c)、甘油三酯(TG)、血肌酐(Scr)、尿素氮(BUN)无明显相关性。
3、糖尿病肾病各组血清IL-18浓度显著高于正常对照组(P<0.01),血清IL-18与UAER成正相关(P<0.01),与空腹血糖(FBG)、餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1c)、甘油三酯(TG)、血肌酐(Scr)、尿素氮(BUN)均成正相关。
4、血清OPN与IL-18之间存在较好的相关性,相关系数为0.97。
结论
2型糖尿病肾病患者较正常对照组存在血清OPN、IL-18水平升高,OPN、IL-18在2型糖尿病肾病患者中随UAER的增加浓度升高,且二者之间存在相关性。OPN、IL-18及慢性炎性病变可能参与了2型糖尿病肾病的发病。
Objective
In this study, we detected the different stages of serum osteopontin and IL - 18 levels in type 2 diabetic nephropathy patients to discuss their role in the development of diabetic nephropathy and whether there is correlation between the two,in order to provide new und- erstanding of pathogenesis and evolution in type 2 diabetic nephropathy.
Methods
We select 90 patients diagnosed as type 2 diabetes from December 2009 to December 2010 in Tai'an Central Hospital, All the cases were confirmed according to the American Diabetes Association(ADA) 2008 diagnostic criteria. According to urinary albumin excretion rate (UAER) they were divided into 3 groups: a simple group of type 2 DM (DM1 group) 30 patients (UAER <20μg/min). Microalbuminuria group (DM2) were 30: (UAER 20μg-200μg/min).Clinical albuminuria group (DM3) were 30: (UAER> 200μg /min). The normal control group consisted of 30 healthy people,who were no significant difference.with theT2DM group in age and sexuality.Serum level of OPN and IL-18 was detected by means of enzyme-linked immunosorbent assay (ELISA). 24-hour urinary albumin excretion rate (UAER) was measured by radio- immunoassay .
Results
1.There were no significant differences between normal control group and diabetic nephropathy group in age,waist-hip ratio and body mass index. Compared with normal control group,Diabetic nephropathy group had statis- tically significant differences in systolic blood pressure, diastolic blood pressure,fasting blood glucose,2-hour postprandial blood glucose, HbA1c(P<0.01).
2. Serum OPN concentration was significantly higher in diabetic nephropathy patients than normal control(P<0.01). Serum OPN was positively correlated with UAER(P< 0.01),and it had no significant correlation with FBG,2hPG,HbA1c,TG,Scr,BUN.
3. Serum IL-18 concentration were significantly higher in diabetic nephropathy patie- nts than normal control(P<0.01). Serum IL-18 was positively correlated with UAER(P<0.01),and it was positively correlated with FBG,2hPG,HbA1c,TG,Scr,BUN.
4. Serum OPN and IL-18 had correlation and the correlation coefficient was 0.97. Conclusion
There was an elevation in the serum level of OPN and IL-18 in type 2 diabetic nephropathy patients.The concentration of OPN and IL-18 increased with UAER increase- ing and OPN was positively correlated with IL-18 in type 2 diabetic nephropathy patients. OPN,IL-18 and chronic inflammatory disease may play an role in the development of type 2 diabetic nephropathy.
本研究通过检测糖尿病肾病患者不同时期血清骨桥蛋白和白细胞介素-18水平变化,旨在探讨二者在糖尿病肾病发生发展中的作用及二者之间是否存在相关性,从而为2型糖尿病肾病的发病机制及演变过程的认识提供新的思路。
方法
选取2009年12月-2010年12月在泰安市中心医院确诊的2型糖尿病患者90例,糖尿病诊断符合2008年美国糖尿病学会(American diabetes association,ADA)的诊断标准。根据尿白蛋白排泄率(UAER)分为3组:单纯2型DM组(DM1组)30例(UAER<20μg/min)。微量白蛋白尿组(DM2组)30例:(UAER 20μg-200μg/min)。临床蛋白尿组(DM3组)30例: (UAER > 200μg/min)。正常对照组(NC组)30例,为体检正常者。性别、年龄两组无统计学差异。采用酶联免疫吸附试验(Enzyme-linked immunosorbent assay,ELISA)测定血清骨桥蛋白(OPN)及白介素-18(IL-18)水平,24小时尿白蛋白排泄率(UAER)采用放免法测定。
结果
1、与健康对照组相比,糖尿病肾病各组在年龄、腰臀比、体重指数方面差异无统计学意义(P>0.05),具有可比性;与健康对照组比较,糖尿病各组收缩压、舒张压、空腹血糖、餐后2h血糖、糖化血红蛋白显著升高,差异有统计学意义(P<0.01)。
2、糖尿病肾病各组血清OPN浓度显著高于正常对照组(P<0.01),血清OPN与UAER成正相关(P<0.01),与空腹血糖(FBG)、餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1c)、甘油三酯(TG)、血肌酐(Scr)、尿素氮(BUN)无明显相关性。
3、糖尿病肾病各组血清IL-18浓度显著高于正常对照组(P<0.01),血清IL-18与UAER成正相关(P<0.01),与空腹血糖(FBG)、餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1c)、甘油三酯(TG)、血肌酐(Scr)、尿素氮(BUN)均成正相关。
4、血清OPN与IL-18之间存在较好的相关性,相关系数为0.97。
结论
2型糖尿病肾病患者较正常对照组存在血清OPN、IL-18水平升高,OPN、IL-18在2型糖尿病肾病患者中随UAER的增加浓度升高,且二者之间存在相关性。OPN、IL-18及慢性炎性病变可能参与了2型糖尿病肾病的发病。
Objective
In this study, we detected the different stages of serum osteopontin and IL - 18 levels in type 2 diabetic nephropathy patients to discuss their role in the development of diabetic nephropathy and whether there is correlation between the two,in order to provide new und- erstanding of pathogenesis and evolution in type 2 diabetic nephropathy.
Methods
We select 90 patients diagnosed as type 2 diabetes from December 2009 to December 2010 in Tai'an Central Hospital, All the cases were confirmed according to the American Diabetes Association(ADA) 2008 diagnostic criteria. According to urinary albumin excretion rate (UAER) they were divided into 3 groups: a simple group of type 2 DM (DM1 group) 30 patients (UAER <20μg/min). Microalbuminuria group (DM2) were 30: (UAER 20μg-200μg/min).Clinical albuminuria group (DM3) were 30: (UAER> 200μg /min). The normal control group consisted of 30 healthy people,who were no significant difference.with theT2DM group in age and sexuality.Serum level of OPN and IL-18 was detected by means of enzyme-linked immunosorbent assay (ELISA). 24-hour urinary albumin excretion rate (UAER) was measured by radio- immunoassay .
Results
1.There were no significant differences between normal control group and diabetic nephropathy group in age,waist-hip ratio and body mass index. Compared with normal control group,Diabetic nephropathy group had statis- tically significant differences in systolic blood pressure, diastolic blood pressure,fasting blood glucose,2-hour postprandial blood glucose, HbA1c(P<0.01).
2. Serum OPN concentration was significantly higher in diabetic nephropathy patients than normal control(P<0.01). Serum OPN was positively correlated with UAER(P< 0.01),and it had no significant correlation with FBG,2hPG,HbA1c,TG,Scr,BUN.
3. Serum IL-18 concentration were significantly higher in diabetic nephropathy patie- nts than normal control(P<0.01). Serum IL-18 was positively correlated with UAER(P<0.01),and it was positively correlated with FBG,2hPG,HbA1c,TG,Scr,BUN.
4. Serum OPN and IL-18 had correlation and the correlation coefficient was 0.97. Conclusion
There was an elevation in the serum level of OPN and IL-18 in type 2 diabetic nephropathy patients.The concentration of OPN and IL-18 increased with UAER increase- ing and OPN was positively correlated with IL-18 in type 2 diabetic nephropathy patients. OPN,IL-18 and chronic inflammatory disease may play an role in the development of type 2 diabetic nephropathy.
引文
[1] Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity[J]. Front Biosci, 2008, 13: 1227- 1239.
[2] David TD,Masaki N,Anthony W, et al.Osteopontin as a means to cope with environmental insults : regulation of inflammation,tissue remodeling,and cell survival [J] . J Clin Invest ,2001 ,107 (9): 1055-1061.
[3] Ahnders F,Dick H,Rikard H, et al.Comment on“The Influence of the Proinflammatory Cytokine ,Osteopontin , on Autoimmune Demyelinating Disease”[J ] . Science , 2003 , 299(21) : 1845-1846.
[4] Mastutani K,Akahoshi M,Tsuruya K,et al.Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum, 2001, 44(5):2097 - 2106.
[5] Nakamura A,Shikata K,Hiramatsu M,et al.Serum Interleukin-18 Levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes[J]. Diabetes Care,2005,28(12):2890-2895.
[6] Esfandiari E,Mclnnes IB,Lindop G,et al.A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol, 2001, 167(9):5338 - 5347.
[7] Aso Y,Okumura K,Takebayashi K,et al.Relationships of plasma Inter- leukin-18 concentrations to hyperhomo-cysteinemia and carotid intimal- media wall thickness in patients with type 2 diabetes[J].Diabetes Care, 2003,26(9):2622-2627.
[8] Thorand B, Kolb H, Baumert J, et al. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/ KORA Augsburg Study, 1984-2002 [J]. Diabetes, 2005, 54(10): 2932- 2938.
[9] Katherine R Tuttle.Linking metabolism and immunology:Diabetic nephropathy is an inflammatory disease.J Am Soc Nephrol,2005,16 (6):1537-1538.
[10]费爱华.中医药治疗2型糖尿病胰岛B细胞功能缺陷的研究近况[J].安徽中医学院学报,2006,25(2):50-52.
[11] Kunsch C ,Medford RM. Oxidative stress as a regulator of gene expre- ssion in the vasculature[J ] . Cire Res ,1999 ,85 (8) :753.
[12] Vnitr L.(TNF-α,IL-1 and 6)and homocysteine in android obesity and the phenomenon of insulin resistance syndromes[J].Diabetes Care 1999, 45(1):11-16.
[13] Barzilay JI,Abaham I,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the cardiovascular health study[J].Diabetes,2001,50(10):2384-2389.
[14] Marciano R,D'Annunzio G,Minuto N,et al.Association of alleles at polymorphic sites in the Osteopontin encoding gene in young type 1 diabetic patients.Clin Immunol. 2009,131(1):84-91.
[15] Katakam AK,Chipitsyna G,Gong Q,et al.Streptozotocin(STZ)mediates acute up- regulation of serum and pancreatic osteopontin(OPN):a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.J Endocrinol.2005 Nov,187(2):237-247.
[16]李珺.董吉祥.骨桥蛋白与糖尿病肾病.国外医学内分泌学分册,2005,25(2):126-128.
[17] Ashkar S,Weber GF,Panoutsakopoulou V,et al.EEta-1(osteopontin):an early com- ponent of type-1 (cell-mediated) immunity. Science, 2000, 28(7): 860-864.
[18] Mueller C,Held W,Imbocen MA,et al.Accelerated B-cell destruction in transferred autoimmune diabetes correlates with an increased expression of the genes codingfor TNF-αand granzyma A in the intra-islet in [J]. Diabetes,1995,44(1):112-117.
[19] Ellen MG. Osteopontin:a bridge between bone and the immune system[J].Clin Invest ,2003 ,112(2) :147-149.
[20] O’Regan AW , Chupp GL , Lowry JA , et al . Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro[J] . J Immunol , 1999 ,162(2) :1024-1031.
[21] Ophascharoensuk V , Giachelli CM, Gordon K, et al.Obstructive uro- pathy in the mouse:role of osteopontin in interstitial fibrosis and apoptosis[J] . Kidney Int , 2001, 56 :571-580.
[22] Stahl RA.Chemoattractants cytokines and immune renal injury.Nephrol Dial Transplant,1999,10:307-327.
[23] Young BA,Burdmann EA,Johnson RJ,et al.Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephro-toxicity.Kidney Int,2000, 48:439-448.
[24] Singh RP,Patarca R,Schwartz J,et al.Definition of a specific interaction between the early T lymphocyte activation 1(Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivoJ.Exp Med,1999,171:1931-1942.
[25] Giachelli CM,Pichler R,Lombardi D,et al.Osteopontin expression in angiotensionⅡ-induced tubulointerstitial nephritis.Kidney Int, 2004, 45:515-524.
[26] Chow F ,Ozols E ,Paterson D ,et al .Macrophages in mouse type 2 diabetic nephro- pathy:correlation with diabetic state and progressive renal injury. Kidney Int, 2004,65:116-128.
[27] Nangaku M.Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med , 2004 , 43:9-17.
[28] Li C ,Yang CW,Park CW,et al .Long-termtreatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int,2003 ,63 :454-463.
[29] Kelly DJ ,Wilkinson-Berka JL ,Ricardo SD ,et al . Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephro- pathy of transgenic (mRen-2) 27 rats. Nephrol Dial Transplant ,2002 ,17 :985-991.
[30] Guo H ,Cai CQ ,Schroeder RA ,et al . Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol ,2001 ,166 :1079-1086.
[31] Thuraisingham RC ,Nott CA ,Dodd SM, et al.Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int ,2000 ,57 :1968-1972.
[32] Junaid A ,Amara FM. Osteopontin:correlation with interstitial fi- brosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells. Histo- pathology ,2004 ,44 :136-146.
[33] Li JH ,Huang XR ,Zhu HJ ,et al.Role of TGF-beta signaling in extra- cellular matrix production under high glucose conditions. Kidney Int , 2003 ,63 :2010-2019.
[34] Takahashi F ,Takahashi K,Okazaki T,et al. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. AmJ Respir Cell Mol Biol,2001, 24 :264-271.
[35] Sodhi CP,Phadke SA,Batlle D,et al.Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis : role of osteopontin. Am Physiol Renal Physiol ,2001 ,280 :F667-F674.
[36] Endlich N ,Sunohara M,Nietfeld W,et al . Analysis of differential gene expression in stretched podocytes:osteopontin enhances adaptation of podocytes to mechanical str- ess. FASEB J ,2002 ,16 :1850-1852.
[37] Lan HY,Yu XQ,Yang N ,et al.De novo glomerular osteopontin expression in rat crescentic glomerulonephritis[J] .Kidney Int,1998,53 :136-145.
[38] Panzer U,Thaiss F,Zahner G,et al.Monocyte chemoattractant Protein-1 and osteo- pontin differentially regulate monocytes recruitment in experimental glomeruloneph- ritis[J] . Kidney Int ,2001 ,59 :1762-1769.
[39] Nitta K,Horita S ,Okano K,et al.Tubular osteopontin expression in patients with ANCA-associated glomerulonephritis [J]. Clin Nephrol, 2001,56 :459-466.
[40] Yu XQ ,Wu LL ,Huang XR , et al.Osteopontin expression in progressive renal injury in remnant kidney : role of angiotensin II[J].Kidney Int ,2000 ,58 :1469-1480.
[41] Kaneto H ,Morrissey J ,McCracken R , et al.Osteopontin expression in the kidney during unilateral ureteral obstruction[J] . Miner Electrolyte Metab ,1998 ,24 :227-237.
[42] Xie Y,Nishi S , Iguchi S , et al.Expression of osteopontin gentamicin-induced acute tubular necrosis and it’s recovery process [J].Kidney Int ,2001,59 :959-974.
[43] Persy VP ,Verstrepen WA, Ysebaert DK, et al.Diffrences in osteopontin upregulation between proximal and distentaltubules after renal ischemia/reperfusion[J] . Kidney Int, 1999 ,56 :601-611.
[44] Persy VP ,Verstrepen WA , Ysebaert DK, et al.Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knock-out mice[J].Kidney Int, 2003, 63 (2) :543-553.
[45] Diamond JR, Kreisberg R, Evans K, et al.Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat[J].Kidney Int, 1998, 54: 1501 -1509.
[46] Li C , Yang CW, Park CW, et al.Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats[J] .Kidney Int , 2003 , 63 (2) :454-463.
[47] Sato N ,Shiraiwa K,Kai K, et al.Mizoribine ameliorates the tubu-lointerstitial fibrosis of obstructive nephropathy [J].Nephron, 2001, 89: 177-185.
[48] Yu XQ,Nikolic-Paterson DJ,Mu W,et al.A functional role for osteopontin in experi- mental crescentic glomerulonephritisinthe rat [J].Proc Assoc Am Physicians, 1998, 110 :50-64.
[49] Aoyama I ,Shimokata K,Niwa T. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis indiabetic rats[J].Nephron, 2002 ,92 (3) :635-651.
[50] Kang DH , Kim YG,Andoh TF , et al.Post-cyclosporine-mediated hyper- tension and nephropathy:amelioration by vascularendothelial growth fac- tor[J]. Am J Physiol Renal Physiol ,2001 ,280 : F727-736.
[51] Moriwaki Y,Yamamoto T,Shibutani Y,et al.Elevated Levels of Inter- leukin-18 and Tumor Necrosis Factor-αin serum of patients with type 2 diabetes mellitus: relation- ship with diabetic nephropathy[J]. Metabolism, 2003,52(5):605-608.
[52] Thorand B,Kolb H,Baumert J,et al.Elevated levels of interleukin-18 predict the development of type 2 diabetes[J]. Diabetes, 2005, 54(10): 2932-2938.
[53] Tilg H,Moschen AR,et al.Inflammatory mechanisms in the regulation of insulin resistance[J].Mol Med,2008,14(3-4):22-31.
[54]许勇芝,陈孝文,刘华锋,等.糖尿病患者外周血白细胞介素-18分泌及基因表达[J].免疫学杂志,2003,19(6):464-466.
[55]肖园园,李竞.初诊2型糖尿病患者胰岛β细胞功能观察[J].临床内科杂志,2006,23(1):38-40.
[56] Netea MG,Kullberg BJ,Verschueren I,et al.Interleukin-18 induces production of proinflammatory cytokines in mice:no intermediate role for the cytokines of the tumor necrosis factor family and interleukin- 1beta[J] Eur J Immunol,2000, 30 (10): 3057 -3060.
[57] MasayoshiYO,YukihiroN,ToshinariT,et al.lnhibitory effete of troglitazone on tumor necrosis factor alpha-induced expression of monoeyte chemoattractant protein-1 in human mesangial cells.Metabolism,2000,49(2):163-166.
[58]刘颖慧,李红.TNF-α与糖尿病肾病.国外医学内分泌学册,2002,22(4):253-256.
[59]秦莹,李竞.细胞间黏附分子-1与糖尿病肾病.医学综述,2006,12(17):1031-1033.
[60]陆再英,钟南山.内科学[M].第七版:人民卫生出版社,2008,776.
[61]刘华锋,陈孝文,吴缓,等.原发性肾小球肾炎患者肾组织白介素-18的表达[J].中华肾脏病杂志,2003,19(2):127.
[62]刘华锋,陈孝文.白细胞介素-18与免疫性肾损伤仁[J].国外医学泌尿系统分册,2000,20(6):244.
[63] Rothe H,Faust A,Sehade U,et al.Cy-clophosphamide treatment of female non-obese diabetic mice causes erdaaneed espression of inducible nitric oxide synthase and interfereon-garmna,but not of interleukin- 4 [J].Diabetologia,1994,37(9):1154.
[64] Purrello F, Rabuazza AM. Metabolic factors that affect beta-cell function and survival [J].Diabetes Nutr Metab,2000,13(12):84-91.
[65] Sivitz WI.Lipotoxicity and glucotoxicity in type 2 diabetes.Effects on development and progression[J].Postgrad Med,2001,109(4): 55-59, 63-64.
[66] Aaltonen P, Luimula P,Astrom E,et al. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest, 2001,81:1185-1190.
[67] Esposito K,Nappo F,Giugliano F,et al.Cytokine milieu tends toward inflammation in type 2 diabetes[J].Diabetes,2003,26(5):1647.
[68] Jonas JC,Sharma A,Hasenkamp W,et al.Chronic hyperglycemia triggers loss of pancreaticβ-cell differentiation in an animal model of diabetes [J].J Biol chem, 1999, 274(20):14112-14121.
[69] Waeber G,Thompson N,Nicod P,et al.Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homelbox factor.Mol Endocrinol, 1996,10(11):1327-1334.
[70]汪玲,郑绍同,陈敏,2型糖尿病患者血清白介素-18肿瘤坏死因子-α与胰岛素抵抗的相关性研究[J].黑龙江医学,2006,30(10):735-737.
[71] Olusi SO,AI-Awadhi A,Abraham M.Relations of serum interleukin-18 levels to serum lipid and glucose concentrations in an apparently healthy adult population[J].Horm Res,2003,60(1):29-33.
[72] Thorand B,Kolb H,Baumert J,et al.Elevated levels of interleukin-18 predict the deve- lopment of type 2 diabetes[J]. Diabetes, 2005,54 (10): 2932-2938.
[73]刘华锋,姚翠微,皇甫长梅等.白细胞介素-18对促进肾小管萎缩和间质纤维化的影响.中国中西医结合肾病杂志,2004,5(12):690-694.
[74] Aso Y,Okumura K,Takebayashi K,et al.Relationships of plasma interleukin-18 con- centrations to hyperhomo-cysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes[J].Diabetes Care,2003,26(9):2622-2627.
[75] Dai SM,Matsuno H,Nakamura H,et al.Interleukin-18 enhances monocyte tumor ncerosis factor alpha and interleukin-1beta produetion induced direct contact with T lymphocytes:implications in rheumatoid arthritis. Arthritis Rheum,2004,50(2): 432 -443.
[76] Stuyt RJ,Netea MG Geijtenbeek TB,et al.Selective regulation of intercellular adhe- sion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes. Immunology,2003,110(3):329-334.
[77] Chandrasekar B,Colston JT,dela Rosa SD,et al.TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation.Biochem Biophys Res Commun,2003,303(4):1152-1158.
[78] Pittoni V,Bombardieri M,SPinelli FR,et al.Anti-tummor necrosis factor(TNF)alpha treatment of theumatoid artliritis (infliximab) selec- tively down regulates the production of interleukin-18 but not of IL-12 and IL-13.Ann Rheum Dis,2002, 61 (8):723-725.
[79]丁鹤林,黎锋,徐明彤,等.抑制核因子κB对糖尿病肾病的作用.中华内科杂志,2002,41(9):605-609.
[80]潘留兰,周晓琦,周玉华,等.乙型肝炎肝硬化患者外周血骨桥蛋白与IL-18水平变化的临床意义[J].中国免疫学杂志,2009,24(12):1130-1132.
[81]马瑞霞,王祥花,刘雪梅,等.骨桥蛋白及白细胞介素- 18在系统性红斑狼疮患者血浆中的表达及意义[J].中国中西医结合肾病杂志,2008,9 (7):622-623.
[1] Mastutani K,Akahoshi M,Tsuruya K, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum,2001, 44(5) :2097 - 2106.
[2] Esfandiari E ,Mclnnes IB ,Lindop G,et al. A proinflammatory role of IL - 18 in the de-velopment of spontaneous autoimmune disease. J Immunol,2001,167(9) :5338 - 5347.
[3] Asaumi S , Takemoto M , Yokote K, et al.Identification and characterization of high glucose and glucosamine responsive element in the rat osteopontin promoter [J].J Diabetes complications ,2003,17(1) :34-38.
[4] Junaid A ,Amara FM. Osteopontin :correlation with interstitial fibro- sis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells. Histo- pathology ,2004 ,44 :136-146.
[5] Aoyama I ,Shimokata K,Niwa T.Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta (1) expression in spontaneously diabetic (OLETF) rats.AmJ Nephrol ,2000 ,20:232-241.
[6] Chow F,Ozols E,Nikolic-Paterson D,et al.Macrophages in mouse type 2 diabetic ne- phropathy:correlation with diabetic state and progressive renalinjury.Kidney Int, 2004, 65:116-128.
[7] Nangaku M.Mechanisms of tubulointerstitial injury in the kidney: final common path- ways to end-stage renal failure. Intern Med ,2004 , 43:9-17.
[8] Li C,Yang CW,Park CW,et al.Long-termtreatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int,2003 ,63:454-463.
[9] Kelly DJ,Wilkinson-Berka JL,Ricardo SD ,et al.Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2) 27 rats. Nephrol Dial Transplant ,2002 ,17 :985-991.
[10] Guo H ,Cai CQ ,Schroeder RA ,et al.Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol ,2001 ,166 :1079-1086.
[11] Li JH ,Huang XR ,Zhu HJ ,et al.Role of TGF-beta signaling in extracellular matrix production under high glucose conditions. Kidney Int ,2003 ,63 :2010-2019.
[12] Takahashi F,Takahashi K,Okazaki T,et al. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. AmJ Respir Cell Mol Biol ,2001,24 :264-271.
[13] Sodhi CP,Phadke SA ,Batlle D,et al.Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis : role of osteopontin. Am Physiol Renal Physiol ,2001 ,280 :F667-F674.
[14] Endlich N,Sunohara M,Nietfeld W,et al.Analysis of differential gene expression in stretched podocytes:osteopontin enhances adaptation of podocytes to mechanical stress. FASEB J ,2002 ,16 :1850-1852.
[15] Dinarello CA.IL-18:a TH1-indueing,Proinflammatory cytokine and new member of the IL-1 family.J Allergy Clin Immunol.1999 Jan;103(1 Pt l):11-24.ReView.
[16] Desaint-VisB,Fugier-Vivier I,MassacrierC,et al.The cytokine Profile expressed by human dendritie cells is dependent on cell subtype and more of activation.J Immunol.1998 Feb 15:160(4):1666-76.
[17] Ushio S,Namba M,okura T,et al.Cloning of the cDNA for human IFN-gamma- indueing factor,expression in Eseheriehia coli,and studies on the biologie activities of the Protein. J Immunol.1996 Jun l;156(11):4274-9.
[18] Novick D, Kim SH, Fantuzzi G,et al.Interleukin-18 binding protein:a novel modulator of the Th1 cytokine response [J]. Immunity, 1999, 10(1):127-136.
[19] Azam T,Novick D,Bufler P,et al.Identification of a criticalIg-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex [J]. Immunol,2003,171(12):6574-6580.
[20] Barbulescu K,Becker C,Schlaak JF,et al.IL-12 and IL-18 differen- tially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lym- phocytes [J].Immunol,1998;160(8):3642.
[21] Puren AJ,Razeghi P,fantuzzi G,et al.Interleukin-18 enhances lipopolysaccharide- induced interferon-gamma pro-duction in human whole blood cultures[J].J Infect Dis,1998,178(6):1830.
[22] Takeda K,Tsutsui H,Yoshimoto T,et al.Defective NK cell activity and Th1 response in IL-18-deficient mice[J].Immunity,1998,8(3):383-390.
[23] Matsumoto S,Tsuji-Takayama K,Aizawa Y,et al.Interleukin-18 acti- vates NF-kappaB in murine T helper type 1 cells[J].Biochem Biophys Res Commun,1997, 234(2): 454- 457.
[24] Tsuji-Takayama K,Matsumoto S,Koide K et al.Interleukin-18 induces activation and association of p56(lck)and MAPK in a murine TH1 clone[J].Biochem Biophys Res Commun,1997,237(1):126-130.
[25]刘华锋,陈孝文,吴瑗,等.原发性肾小球肾炎患者肾组织白介素-18的表达[J] .中华肾脏病杂志,2003 ,19 (2) :127.
[26]刘华锋,陈孝文.白细胞介素- 18与免疫性肾损伤[J].国外医学泌尿系统分册,2000 ,20 (6) :244.
[27] Rothe H , Faust A , Schade U , et al. Cyclophosphamide treatment of female nonobese diabetic mice causes enhanced espression of inducible nitric oxide synthase and interferon-gamma ,but not of interleukin-4 [ J ] . Diabetologia , 1994 , 37(9) :1154.
[28] Nakamura A, Shikata K, Hiramatsu M, et al.Serum interleukin-18 levels are asso-ciated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes [J].Diabetes Care, 2005; 28 (12) : 2890-2895.
[29]潘留兰,周晓琦,周玉华,等.乙型肝炎肝硬化患者外周血骨桥蛋白与IL-18水平变化的临床意义[J].中国免疫学杂志,2009,24(12):1130-1132.
[30]马瑞霞,王祥花,刘雪梅,等.骨桥蛋白及白细胞介素- 18在系统性红斑狼疮患者血浆中的表达及意义[J].中国中西医结合肾病杂志,2008,9 (7):622-623.
[2] David TD,Masaki N,Anthony W, et al.Osteopontin as a means to cope with environmental insults : regulation of inflammation,tissue remodeling,and cell survival [J] . J Clin Invest ,2001 ,107 (9): 1055-1061.
[3] Ahnders F,Dick H,Rikard H, et al.Comment on“The Influence of the Proinflammatory Cytokine ,Osteopontin , on Autoimmune Demyelinating Disease”[J ] . Science , 2003 , 299(21) : 1845-1846.
[4] Mastutani K,Akahoshi M,Tsuruya K,et al.Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum, 2001, 44(5):2097 - 2106.
[5] Nakamura A,Shikata K,Hiramatsu M,et al.Serum Interleukin-18 Levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes[J]. Diabetes Care,2005,28(12):2890-2895.
[6] Esfandiari E,Mclnnes IB,Lindop G,et al.A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol, 2001, 167(9):5338 - 5347.
[7] Aso Y,Okumura K,Takebayashi K,et al.Relationships of plasma Inter- leukin-18 concentrations to hyperhomo-cysteinemia and carotid intimal- media wall thickness in patients with type 2 diabetes[J].Diabetes Care, 2003,26(9):2622-2627.
[8] Thorand B, Kolb H, Baumert J, et al. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/ KORA Augsburg Study, 1984-2002 [J]. Diabetes, 2005, 54(10): 2932- 2938.
[9] Katherine R Tuttle.Linking metabolism and immunology:Diabetic nephropathy is an inflammatory disease.J Am Soc Nephrol,2005,16 (6):1537-1538.
[10]费爱华.中医药治疗2型糖尿病胰岛B细胞功能缺陷的研究近况[J].安徽中医学院学报,2006,25(2):50-52.
[11] Kunsch C ,Medford RM. Oxidative stress as a regulator of gene expre- ssion in the vasculature[J ] . Cire Res ,1999 ,85 (8) :753.
[12] Vnitr L.(TNF-α,IL-1 and 6)and homocysteine in android obesity and the phenomenon of insulin resistance syndromes[J].Diabetes Care 1999, 45(1):11-16.
[13] Barzilay JI,Abaham I,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the cardiovascular health study[J].Diabetes,2001,50(10):2384-2389.
[14] Marciano R,D'Annunzio G,Minuto N,et al.Association of alleles at polymorphic sites in the Osteopontin encoding gene in young type 1 diabetic patients.Clin Immunol. 2009,131(1):84-91.
[15] Katakam AK,Chipitsyna G,Gong Q,et al.Streptozotocin(STZ)mediates acute up- regulation of serum and pancreatic osteopontin(OPN):a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.J Endocrinol.2005 Nov,187(2):237-247.
[16]李珺.董吉祥.骨桥蛋白与糖尿病肾病.国外医学内分泌学分册,2005,25(2):126-128.
[17] Ashkar S,Weber GF,Panoutsakopoulou V,et al.EEta-1(osteopontin):an early com- ponent of type-1 (cell-mediated) immunity. Science, 2000, 28(7): 860-864.
[18] Mueller C,Held W,Imbocen MA,et al.Accelerated B-cell destruction in transferred autoimmune diabetes correlates with an increased expression of the genes codingfor TNF-αand granzyma A in the intra-islet in [J]. Diabetes,1995,44(1):112-117.
[19] Ellen MG. Osteopontin:a bridge between bone and the immune system[J].Clin Invest ,2003 ,112(2) :147-149.
[20] O’Regan AW , Chupp GL , Lowry JA , et al . Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro[J] . J Immunol , 1999 ,162(2) :1024-1031.
[21] Ophascharoensuk V , Giachelli CM, Gordon K, et al.Obstructive uro- pathy in the mouse:role of osteopontin in interstitial fibrosis and apoptosis[J] . Kidney Int , 2001, 56 :571-580.
[22] Stahl RA.Chemoattractants cytokines and immune renal injury.Nephrol Dial Transplant,1999,10:307-327.
[23] Young BA,Burdmann EA,Johnson RJ,et al.Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephro-toxicity.Kidney Int,2000, 48:439-448.
[24] Singh RP,Patarca R,Schwartz J,et al.Definition of a specific interaction between the early T lymphocyte activation 1(Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivoJ.Exp Med,1999,171:1931-1942.
[25] Giachelli CM,Pichler R,Lombardi D,et al.Osteopontin expression in angiotensionⅡ-induced tubulointerstitial nephritis.Kidney Int, 2004, 45:515-524.
[26] Chow F ,Ozols E ,Paterson D ,et al .Macrophages in mouse type 2 diabetic nephro- pathy:correlation with diabetic state and progressive renal injury. Kidney Int, 2004,65:116-128.
[27] Nangaku M.Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med , 2004 , 43:9-17.
[28] Li C ,Yang CW,Park CW,et al .Long-termtreatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int,2003 ,63 :454-463.
[29] Kelly DJ ,Wilkinson-Berka JL ,Ricardo SD ,et al . Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephro- pathy of transgenic (mRen-2) 27 rats. Nephrol Dial Transplant ,2002 ,17 :985-991.
[30] Guo H ,Cai CQ ,Schroeder RA ,et al . Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol ,2001 ,166 :1079-1086.
[31] Thuraisingham RC ,Nott CA ,Dodd SM, et al.Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int ,2000 ,57 :1968-1972.
[32] Junaid A ,Amara FM. Osteopontin:correlation with interstitial fi- brosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells. Histo- pathology ,2004 ,44 :136-146.
[33] Li JH ,Huang XR ,Zhu HJ ,et al.Role of TGF-beta signaling in extra- cellular matrix production under high glucose conditions. Kidney Int , 2003 ,63 :2010-2019.
[34] Takahashi F ,Takahashi K,Okazaki T,et al. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. AmJ Respir Cell Mol Biol,2001, 24 :264-271.
[35] Sodhi CP,Phadke SA,Batlle D,et al.Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis : role of osteopontin. Am Physiol Renal Physiol ,2001 ,280 :F667-F674.
[36] Endlich N ,Sunohara M,Nietfeld W,et al . Analysis of differential gene expression in stretched podocytes:osteopontin enhances adaptation of podocytes to mechanical str- ess. FASEB J ,2002 ,16 :1850-1852.
[37] Lan HY,Yu XQ,Yang N ,et al.De novo glomerular osteopontin expression in rat crescentic glomerulonephritis[J] .Kidney Int,1998,53 :136-145.
[38] Panzer U,Thaiss F,Zahner G,et al.Monocyte chemoattractant Protein-1 and osteo- pontin differentially regulate monocytes recruitment in experimental glomeruloneph- ritis[J] . Kidney Int ,2001 ,59 :1762-1769.
[39] Nitta K,Horita S ,Okano K,et al.Tubular osteopontin expression in patients with ANCA-associated glomerulonephritis [J]. Clin Nephrol, 2001,56 :459-466.
[40] Yu XQ ,Wu LL ,Huang XR , et al.Osteopontin expression in progressive renal injury in remnant kidney : role of angiotensin II[J].Kidney Int ,2000 ,58 :1469-1480.
[41] Kaneto H ,Morrissey J ,McCracken R , et al.Osteopontin expression in the kidney during unilateral ureteral obstruction[J] . Miner Electrolyte Metab ,1998 ,24 :227-237.
[42] Xie Y,Nishi S , Iguchi S , et al.Expression of osteopontin gentamicin-induced acute tubular necrosis and it’s recovery process [J].Kidney Int ,2001,59 :959-974.
[43] Persy VP ,Verstrepen WA, Ysebaert DK, et al.Diffrences in osteopontin upregulation between proximal and distentaltubules after renal ischemia/reperfusion[J] . Kidney Int, 1999 ,56 :601-611.
[44] Persy VP ,Verstrepen WA , Ysebaert DK, et al.Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knock-out mice[J].Kidney Int, 2003, 63 (2) :543-553.
[45] Diamond JR, Kreisberg R, Evans K, et al.Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat[J].Kidney Int, 1998, 54: 1501 -1509.
[46] Li C , Yang CW, Park CW, et al.Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats[J] .Kidney Int , 2003 , 63 (2) :454-463.
[47] Sato N ,Shiraiwa K,Kai K, et al.Mizoribine ameliorates the tubu-lointerstitial fibrosis of obstructive nephropathy [J].Nephron, 2001, 89: 177-185.
[48] Yu XQ,Nikolic-Paterson DJ,Mu W,et al.A functional role for osteopontin in experi- mental crescentic glomerulonephritisinthe rat [J].Proc Assoc Am Physicians, 1998, 110 :50-64.
[49] Aoyama I ,Shimokata K,Niwa T. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis indiabetic rats[J].Nephron, 2002 ,92 (3) :635-651.
[50] Kang DH , Kim YG,Andoh TF , et al.Post-cyclosporine-mediated hyper- tension and nephropathy:amelioration by vascularendothelial growth fac- tor[J]. Am J Physiol Renal Physiol ,2001 ,280 : F727-736.
[51] Moriwaki Y,Yamamoto T,Shibutani Y,et al.Elevated Levels of Inter- leukin-18 and Tumor Necrosis Factor-αin serum of patients with type 2 diabetes mellitus: relation- ship with diabetic nephropathy[J]. Metabolism, 2003,52(5):605-608.
[52] Thorand B,Kolb H,Baumert J,et al.Elevated levels of interleukin-18 predict the development of type 2 diabetes[J]. Diabetes, 2005, 54(10): 2932-2938.
[53] Tilg H,Moschen AR,et al.Inflammatory mechanisms in the regulation of insulin resistance[J].Mol Med,2008,14(3-4):22-31.
[54]许勇芝,陈孝文,刘华锋,等.糖尿病患者外周血白细胞介素-18分泌及基因表达[J].免疫学杂志,2003,19(6):464-466.
[55]肖园园,李竞.初诊2型糖尿病患者胰岛β细胞功能观察[J].临床内科杂志,2006,23(1):38-40.
[56] Netea MG,Kullberg BJ,Verschueren I,et al.Interleukin-18 induces production of proinflammatory cytokines in mice:no intermediate role for the cytokines of the tumor necrosis factor family and interleukin- 1beta[J] Eur J Immunol,2000, 30 (10): 3057 -3060.
[57] MasayoshiYO,YukihiroN,ToshinariT,et al.lnhibitory effete of troglitazone on tumor necrosis factor alpha-induced expression of monoeyte chemoattractant protein-1 in human mesangial cells.Metabolism,2000,49(2):163-166.
[58]刘颖慧,李红.TNF-α与糖尿病肾病.国外医学内分泌学册,2002,22(4):253-256.
[59]秦莹,李竞.细胞间黏附分子-1与糖尿病肾病.医学综述,2006,12(17):1031-1033.
[60]陆再英,钟南山.内科学[M].第七版:人民卫生出版社,2008,776.
[61]刘华锋,陈孝文,吴缓,等.原发性肾小球肾炎患者肾组织白介素-18的表达[J].中华肾脏病杂志,2003,19(2):127.
[62]刘华锋,陈孝文.白细胞介素-18与免疫性肾损伤仁[J].国外医学泌尿系统分册,2000,20(6):244.
[63] Rothe H,Faust A,Sehade U,et al.Cy-clophosphamide treatment of female non-obese diabetic mice causes erdaaneed espression of inducible nitric oxide synthase and interfereon-garmna,but not of interleukin- 4 [J].Diabetologia,1994,37(9):1154.
[64] Purrello F, Rabuazza AM. Metabolic factors that affect beta-cell function and survival [J].Diabetes Nutr Metab,2000,13(12):84-91.
[65] Sivitz WI.Lipotoxicity and glucotoxicity in type 2 diabetes.Effects on development and progression[J].Postgrad Med,2001,109(4): 55-59, 63-64.
[66] Aaltonen P, Luimula P,Astrom E,et al. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest, 2001,81:1185-1190.
[67] Esposito K,Nappo F,Giugliano F,et al.Cytokine milieu tends toward inflammation in type 2 diabetes[J].Diabetes,2003,26(5):1647.
[68] Jonas JC,Sharma A,Hasenkamp W,et al.Chronic hyperglycemia triggers loss of pancreaticβ-cell differentiation in an animal model of diabetes [J].J Biol chem, 1999, 274(20):14112-14121.
[69] Waeber G,Thompson N,Nicod P,et al.Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homelbox factor.Mol Endocrinol, 1996,10(11):1327-1334.
[70]汪玲,郑绍同,陈敏,2型糖尿病患者血清白介素-18肿瘤坏死因子-α与胰岛素抵抗的相关性研究[J].黑龙江医学,2006,30(10):735-737.
[71] Olusi SO,AI-Awadhi A,Abraham M.Relations of serum interleukin-18 levels to serum lipid and glucose concentrations in an apparently healthy adult population[J].Horm Res,2003,60(1):29-33.
[72] Thorand B,Kolb H,Baumert J,et al.Elevated levels of interleukin-18 predict the deve- lopment of type 2 diabetes[J]. Diabetes, 2005,54 (10): 2932-2938.
[73]刘华锋,姚翠微,皇甫长梅等.白细胞介素-18对促进肾小管萎缩和间质纤维化的影响.中国中西医结合肾病杂志,2004,5(12):690-694.
[74] Aso Y,Okumura K,Takebayashi K,et al.Relationships of plasma interleukin-18 con- centrations to hyperhomo-cysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes[J].Diabetes Care,2003,26(9):2622-2627.
[75] Dai SM,Matsuno H,Nakamura H,et al.Interleukin-18 enhances monocyte tumor ncerosis factor alpha and interleukin-1beta produetion induced direct contact with T lymphocytes:implications in rheumatoid arthritis. Arthritis Rheum,2004,50(2): 432 -443.
[76] Stuyt RJ,Netea MG Geijtenbeek TB,et al.Selective regulation of intercellular adhe- sion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes. Immunology,2003,110(3):329-334.
[77] Chandrasekar B,Colston JT,dela Rosa SD,et al.TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation.Biochem Biophys Res Commun,2003,303(4):1152-1158.
[78] Pittoni V,Bombardieri M,SPinelli FR,et al.Anti-tummor necrosis factor(TNF)alpha treatment of theumatoid artliritis (infliximab) selec- tively down regulates the production of interleukin-18 but not of IL-12 and IL-13.Ann Rheum Dis,2002, 61 (8):723-725.
[79]丁鹤林,黎锋,徐明彤,等.抑制核因子κB对糖尿病肾病的作用.中华内科杂志,2002,41(9):605-609.
[80]潘留兰,周晓琦,周玉华,等.乙型肝炎肝硬化患者外周血骨桥蛋白与IL-18水平变化的临床意义[J].中国免疫学杂志,2009,24(12):1130-1132.
[81]马瑞霞,王祥花,刘雪梅,等.骨桥蛋白及白细胞介素- 18在系统性红斑狼疮患者血浆中的表达及意义[J].中国中西医结合肾病杂志,2008,9 (7):622-623.
[1] Mastutani K,Akahoshi M,Tsuruya K, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum,2001, 44(5) :2097 - 2106.
[2] Esfandiari E ,Mclnnes IB ,Lindop G,et al. A proinflammatory role of IL - 18 in the de-velopment of spontaneous autoimmune disease. J Immunol,2001,167(9) :5338 - 5347.
[3] Asaumi S , Takemoto M , Yokote K, et al.Identification and characterization of high glucose and glucosamine responsive element in the rat osteopontin promoter [J].J Diabetes complications ,2003,17(1) :34-38.
[4] Junaid A ,Amara FM. Osteopontin :correlation with interstitial fibro- sis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells. Histo- pathology ,2004 ,44 :136-146.
[5] Aoyama I ,Shimokata K,Niwa T.Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta (1) expression in spontaneously diabetic (OLETF) rats.AmJ Nephrol ,2000 ,20:232-241.
[6] Chow F,Ozols E,Nikolic-Paterson D,et al.Macrophages in mouse type 2 diabetic ne- phropathy:correlation with diabetic state and progressive renalinjury.Kidney Int, 2004, 65:116-128.
[7] Nangaku M.Mechanisms of tubulointerstitial injury in the kidney: final common path- ways to end-stage renal failure. Intern Med ,2004 , 43:9-17.
[8] Li C,Yang CW,Park CW,et al.Long-termtreatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int,2003 ,63:454-463.
[9] Kelly DJ,Wilkinson-Berka JL,Ricardo SD ,et al.Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2) 27 rats. Nephrol Dial Transplant ,2002 ,17 :985-991.
[10] Guo H ,Cai CQ ,Schroeder RA ,et al.Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol ,2001 ,166 :1079-1086.
[11] Li JH ,Huang XR ,Zhu HJ ,et al.Role of TGF-beta signaling in extracellular matrix production under high glucose conditions. Kidney Int ,2003 ,63 :2010-2019.
[12] Takahashi F,Takahashi K,Okazaki T,et al. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. AmJ Respir Cell Mol Biol ,2001,24 :264-271.
[13] Sodhi CP,Phadke SA ,Batlle D,et al.Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis : role of osteopontin. Am Physiol Renal Physiol ,2001 ,280 :F667-F674.
[14] Endlich N,Sunohara M,Nietfeld W,et al.Analysis of differential gene expression in stretched podocytes:osteopontin enhances adaptation of podocytes to mechanical stress. FASEB J ,2002 ,16 :1850-1852.
[15] Dinarello CA.IL-18:a TH1-indueing,Proinflammatory cytokine and new member of the IL-1 family.J Allergy Clin Immunol.1999 Jan;103(1 Pt l):11-24.ReView.
[16] Desaint-VisB,Fugier-Vivier I,MassacrierC,et al.The cytokine Profile expressed by human dendritie cells is dependent on cell subtype and more of activation.J Immunol.1998 Feb 15:160(4):1666-76.
[17] Ushio S,Namba M,okura T,et al.Cloning of the cDNA for human IFN-gamma- indueing factor,expression in Eseheriehia coli,and studies on the biologie activities of the Protein. J Immunol.1996 Jun l;156(11):4274-9.
[18] Novick D, Kim SH, Fantuzzi G,et al.Interleukin-18 binding protein:a novel modulator of the Th1 cytokine response [J]. Immunity, 1999, 10(1):127-136.
[19] Azam T,Novick D,Bufler P,et al.Identification of a criticalIg-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex [J]. Immunol,2003,171(12):6574-6580.
[20] Barbulescu K,Becker C,Schlaak JF,et al.IL-12 and IL-18 differen- tially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lym- phocytes [J].Immunol,1998;160(8):3642.
[21] Puren AJ,Razeghi P,fantuzzi G,et al.Interleukin-18 enhances lipopolysaccharide- induced interferon-gamma pro-duction in human whole blood cultures[J].J Infect Dis,1998,178(6):1830.
[22] Takeda K,Tsutsui H,Yoshimoto T,et al.Defective NK cell activity and Th1 response in IL-18-deficient mice[J].Immunity,1998,8(3):383-390.
[23] Matsumoto S,Tsuji-Takayama K,Aizawa Y,et al.Interleukin-18 acti- vates NF-kappaB in murine T helper type 1 cells[J].Biochem Biophys Res Commun,1997, 234(2): 454- 457.
[24] Tsuji-Takayama K,Matsumoto S,Koide K et al.Interleukin-18 induces activation and association of p56(lck)and MAPK in a murine TH1 clone[J].Biochem Biophys Res Commun,1997,237(1):126-130.
[25]刘华锋,陈孝文,吴瑗,等.原发性肾小球肾炎患者肾组织白介素-18的表达[J] .中华肾脏病杂志,2003 ,19 (2) :127.
[26]刘华锋,陈孝文.白细胞介素- 18与免疫性肾损伤[J].国外医学泌尿系统分册,2000 ,20 (6) :244.
[27] Rothe H , Faust A , Schade U , et al. Cyclophosphamide treatment of female nonobese diabetic mice causes enhanced espression of inducible nitric oxide synthase and interferon-gamma ,but not of interleukin-4 [ J ] . Diabetologia , 1994 , 37(9) :1154.
[28] Nakamura A, Shikata K, Hiramatsu M, et al.Serum interleukin-18 levels are asso-ciated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes [J].Diabetes Care, 2005; 28 (12) : 2890-2895.
[29]潘留兰,周晓琦,周玉华,等.乙型肝炎肝硬化患者外周血骨桥蛋白与IL-18水平变化的临床意义[J].中国免疫学杂志,2009,24(12):1130-1132.
[30]马瑞霞,王祥花,刘雪梅,等.骨桥蛋白及白细胞介素- 18在系统性红斑狼疮患者血浆中的表达及意义[J].中国中西医结合肾病杂志,2008,9 (7):622-623.